Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00002038 · ClinicalTrials.gov registry record · NA
Non-Comparative Study of Fluconazole in Patients With Serious Mycoses and Who Cannot Be Treated With Conventional Antifungal Therapy
A NA study, sponsored by Pfizer.
- Completed
- Registry status
- NA
- Development phase
NCT00002038: Completed NA study, sponsored by Pfizer.
NCT00002038 is a NA study that has completed, run by Pfizer. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00002038, a NA study, has completed, sponsored by Pfizer.
- COMPLETED
- Registry status
- NA
- Development phase
Study Summary
The primary purpose of this protocol is to provide fluconazole for the treatment of individual patients who require therapy for serious or life-threatening systemic fungal infection, who have failed on conventional antifungal therapy or have had unacceptable reactions to conventional antifungal therapy, and who are ineligible for other established fluconazole clinical trial protocols.
Interventions
- DRUG Fluconazole
Trial Details
| Field | Value |
|---|---|
| Phase | NA |
What the finished NCT00002038 record still lists
NCT00002038 is an interventional study that assigns participants to a tested intervention. An enrollment target was not published in the registry record, which is common for early-stage or observational entries.
The record links to 0 conditions, and to 1 intervention - of which Fluconazole is the first listed.
NCT00002038 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00002038 about?
NCT00002038 is a clinical study titled "Non-Comparative Study of Fluconazole in Patients With Serious Mycoses and Who Cannot Be Treated With Conventional Antifungal Therapy". The primary purpose of this protocol is to provide fluconazole for the treatment of individual patients who require therapy for serious or life-threatening systemic fungal infection, who have failed on conventional antifungal therapy or have had unacceptable reactions to conventional antifungal ther...
What is the current status of trial NCT00002038?
This trial is currently completed. It is a NA study.
What interventions are being tested in trial NCT00002038?
The interventions under investigation include: Fluconazole (DRUG).
Who is sponsoring clinical trial NCT00002038?
This trial is sponsored by Pfizer, which has 1,845 total clinical trials registered on ClinicalTrials.gov.